West Pharmaceutical Services PE Ratio 2010-2024 | WST

Current and historical p/e ratio for West Pharmaceutical Services (WST) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. West Pharmaceutical Services PE ratio as of April 29, 2025 is 29.91.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

West Pharmaceutical Services PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-04-29 213.46 31.91
2024-12-31 327.35 $6.69 48.93
2024-09-30 299.78 $6.74 44.48
2024-06-30 328.75 $7.03 46.76
2024-03-31 394.73 $7.58 52.08
2023-12-31 351.06 $7.88 44.55
2023-09-30 373.86 $7.41 50.45
2023-06-30 380.90 $6.86 55.52
2023-03-31 344.87 $7.28 47.37
2022-12-31 234.09 $7.72 30.32
2022-09-30 244.56 $8.29 29.50
2022-06-30 300.32 $9.01 33.33
2022-03-31 407.72 $9.00 45.30
2021-12-31 465.38 $8.70 53.49
2021-09-30 421.07 $8.06 52.24
2021-06-30 356.00 $6.84 52.05
2021-03-31 279.20 $5.58 50.04
2020-12-31 280.56 $4.58 61.26
2020-09-30 272.07 $4.13 65.88
2020-06-30 224.70 $3.79 59.29
2020-03-31 150.45 $3.46 43.48
2019-12-31 148.40 $3.20 46.38
2019-09-30 139.84 $3.05 45.85
2019-06-30 123.26 $3.03 40.68
2019-03-31 108.39 $2.90 37.38
2018-12-31 96.28 $2.75 35.01
2018-09-30 121.11 $2.06 58.79
2018-06-30 97.25 $2.00 48.63
2018-03-31 86.34 $1.76 49.06
2017-12-31 96.36 $1.99 48.42
2017-09-30 93.87 $2.51 37.40
2017-06-30 92.04 $2.34 39.33
2017-03-31 79.34 $2.43 32.65
2016-12-31 82.35 $1.92 42.89
2016-09-30 72.19 $1.85 39.02
2016-06-30 73.41 $1.37 53.59
2016-03-31 66.95 $1.15 58.22
2015-12-31 58.04 $1.30 44.65
2015-09-30 52.05 $1.28 40.66
2015-06-30 55.76 $1.69 32.99
2015-03-31 57.69 $1.83 31.52
2014-12-31 50.90 $1.76 28.92
2014-09-30 42.69 $1.66 25.72
2014-06-30 40.13 $1.60 25.08
2014-03-31 41.81 $1.51 27.69
2013-12-31 46.47 $1.58 29.41
2013-09-30 38.90 $1.55 25.09
2013-06-30 33.12 $1.40 23.74
2013-03-31 30.52 $1.19 25.65
2012-12-31 25.64 $1.15 22.40
2012-09-30 24.77 $1.12 22.21
2012-06-30 23.48 $1.15 20.51
2012-03-31 19.69 $1.21 16.34
2011-12-31 17.49 $1.08 16.19
2011-09-30 17.02 $0.90 18.91
2011-06-30 20.00 $0.91 21.97
2011-03-31 20.38 $0.94 21.80
2010-12-31 18.68 $0.94 19.87
2010-09-30 15.48 $1.15 13.52
2010-06-30 16.39 $1.14 14.38
2010-03-31 18.77 $1.12 16.84
2009-12-31 17.47 $1.06 16.48
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $14.596B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $87.363B 23.91
Becton Dickinson (BDX) United States $57.057B 14.28
Cardinal Health (CAH) United States $32.542B 17.43
Straumann Holding AG (SAUHY) Switzerland $18.704B 0.00
Labcorp (LH) United States $18.166B 14.90
Cooper (COO) United States $15.901B 21.09
Align Technology (ALGN) United States $12.549B 24.31
Henry Schein (HSIC) United States $7.930B 13.66
Merit Medical Systems (MMSI) United States $5.369B 26.12
Patterson (PDCO) United States $2.772B 15.98
DENTSPLY SIRONA (XRAY) United States $2.557B 7.68
CONMED (CNMD) United States $1.503B 11.68
STAAR Surgical (STAA) United States $0.833B 0.00
Pro-Dex (PDEX) United States $0.198B 30.26
Lifevantage (LFVN) United States $0.169B 18.65